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Research
here is little documented research
examining disparities in cancer serv-
ices between the Indigenous and
non-Indigenous populations of Australia.
Surgical procedures for cancer have received
almost no attention, although differences
have been seen between Indigenous patients
and other patients in utilisation of hospital
procedures, including those for all neo-
plasms combined.1,2 Inequalities in access to
cardiovascular healthcare have also been
reported.3 Furthermore, living in a rural
area in Australia has been shown to affect
cancer treatment patterns,4,5 and being
treated in a rural hospital has been shown to
worsen patient outcomes.4,5 The finding of a
lower total procedure rate in the Indigenous
population1,2 is consistent with these find-
ings.
Our exploratory study aimed to examine
possible disparities between the Indigenous
and non-Indigenous populations of Western
Australia (WA) in the uptake of cancer
surgery for three common cancers (breast,
prostate and lung), using administrative
data collected routinely over 20 years.
METHODS
Data sources and patients
The WA Record Linkage Project was used to
extract all hospital morbidity, cancer regis-
trations and death records for all residents of
WA who:
• had a mention in any record of cancer of
the breast (codes, ICD-9 1746 or ICD-10
C507), prostate (ICD-9 185 or ICD-10 C61)
or lung (ICD-9 162 or ICD-10 C33); or,
• if there was no cancer registration, had a
hospital record with the cancer identified
together with an associated procedure.
Patients were included if they had an
incident date for breast cancer between 1
January 1982 and 31 December 2000, or,
for prostate or lung cancer, between 1 Janu-
ary 1982 and 31 December 2001. As breast
cancer data were extracted earlier, the 2001
data were incomplete and not used.
Data extraction
The Record Linkage Project contains data
for each patient for each hospital admission.
The first record that mentioned the cancer of
interest was labelled the index admission;
any cancer or death record details were
added to this record.
Patient age and marital status at the time
of the index admission were used to adjust
for confounding in the logistic regression
models. Other variables were created for use
in the regression model, including:
Indigenous status. Due to variability in the
recording of this status, any mention in any
hospital, cancer or death record was added
to the index admission record.
Calendar period. For breast cancer, the date
of diagnosis was categorised as 1982–1986,
1987–1991, 1992–1996 or 1997–2000; for
lung cancer, the final category was 1997–
2001. As diagnoses of prostate cancer
increased greatly when testing for prostate-
specific antigen (PSA) was added to the
Medicare Benefits Schedule in 1993,8 date of
diagnosis was categorised as pre-, peri- or
post-PSA testing (1982–1992, 1993–1996
and 1997–2001, respectively).
Comorbidity. ICD codes in the hospital mor-
bidity records for the index admission and
admissions in the previous year (excluding
the cancer of interest) were used to adjust
for comorbidity using the Charlson Morbid-
ity Index.9
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Indices of disadvantage. The Index of Relative
Socioeconomic Disadvantage (IRSD)10 and
the Accessibility/Remoteness Index of Aus-
tralia (ARIA)11 for the place of residence
were added to the record based on the
Australian Bureau of Statistics census collec-
tion districts (where unavailable, the post-
code was used). The hospital of the index
admission was categorised as public or pri-
vate and as metropolitan or rural. The pay-
ment classification of the patient at the
index admission was recoded as public or
private.
Definitions of surgery. Lung cancer surgery
was defined as one or more of pneumon-
ectomy, lobectomy, segmentectomy, wedge
resection or excision/resection of the bron-
chus or endotrachea. Prostate cancer surgery
was defined as either radical or non-radical
prostatectomy (including closed, trans-
urethral, or open). For breast cancer, only
women who underwent mastectomy or
breast-conserving surgery were included, as
the principal aim was to examine differences
in patterns of surgical treatment rather than
use of surgery per se. There were no Indigen-
ous non-surgery breast cancer cases.
Statistical analysis
Univariate analysis was carried out, followed
by crude and adjusted logistic regression
analysis of the likelihood of receiving sur-
gery for lung and prostate cancer, or breast-
conserving surgery for breast cancer. The
adjusted analyses used the demographic,
comorbidity and disadvantage indices (Box
1). For age, the Box–Tidwell term (age ×
ln[age]) was used to provide a better fit of
the model for adjustment purposes. The
data were analysed using SPSS for Windows
(Version 10.0.7.)12 and Stata 8.13
The study was approved by the Human
Research Ethics Committee of the University
of Western Australia.
RESULTS
The Indigenous population accounted for
2% of lung cancer cases. The Indigenous
patients were younger and more likely to be
female than the non-Indigenous patients
(Box 1). Among the lung cancer patients
who received surgical intervention, age and
sex distribution were similar in the Indi-
genous and non-Indigenous groups. There
was a tendency for Indigenous cases to not
receive surgery, although this only reached
significance with the longer time period
(1982–2001) (Box 2).
Very few Indigenous men were recorded
as having prostate cancer. The mean age of
the Indigenous and non-Indigenous groups
was similar. A much smaller proportion of
Indigenous patients received radical or non-
radical prostatectomy (Box 1). As only one
Indigenous person received a radical prosta-
tectomy, logistic regression was not per-
formed. The likelihood of receiving non-
radical prostatectomy was lower for Indi-
genous patients than for non-Indigenous
patients in the demographically adjusted
model but not in the fully adjusted model
(Box 2).
Among women with breast cancer there
was no difference between Indigenous and
non-Indigenous groups in the proportion
who received breast-conserving surgery
(Box 1). Likewise, the ages of the groups
were similar. Logistic regression showed that
Indigenous women had similar treatment
patterns to non-Indigenous women (Box 2).
DISCUSSION
In general, the Indigenous population with
lung or prostate cancer were less likely to
receive a surgical procedure for their cancer
than the non-Indigenous population. How-
ever, Indigenous women with breast cancer
had a pattern of surgery similar to that of
non-Indigenous women.
Age-standardised cancer incidence rates
have tended to be lower in the Indigenous
population than in the non-Indigenous pop-
ulation.14 In part, this may be attributable to
known difficulties in identifying all Indi-
genous people in the hospital, cancer and
death registries,15 which would result in the
true effect of being Indigenous being under-
estimated. Furthermore, poor life expect-
ancy for Indigenous people may mask
cancers that are latent at the time of early
death. The small numbers of diagnosed and
identified cases limit the potential of the
statistical analysis to illuminate treatment
patterns and outcomes in the Indigenous
population.
There is some evidence that Indigenous
people with cancer in Australia generally
have higher case fatality rates.16 This may be
due to a higher relative incidence of cancers
with high fatality, particularly lung can-
cer,14,17 later diagnosis or suboptimal treat-
ment patterns. We found no difference in
breast cancer treatment patterns, whereas
there were differences in lung and prostate
cancer treatment patterns.
Sociocultural and economic factors may
influence treatment patterns and outcomes,
1 Demographic characteristics of cancer patients in Western Australia, 
1982–2001, and proportions who underwent surgery
Non-Indigenous Indigenous P
Lung cancer
Total with lung cancer (% of all cases) 13103 (98.0%) 274 (2.0%)
Age in years (mean [SD]) 67.4 (11.1) 61.7 (12.5) < 0.01
Number who were male (%) 9222 (70.4%) 159 (58.0%) < 0.01
Received lung cancer surgery (%) 1693 (12.9%) 26 (9.5%) 0.08
Age in years (mean [SD]) 64.0 (10.5) 61.8 (11.7) 0.29
Number who were male (%) 1160 (68.5%) 15 (57.7%) 0.24
Prostate cancer
Men with prostate cancer (% of all cases) 14123 (99.5%) 64 (0.5%)
Age in years (mean [SD]) 72.0 (9.3) 72.4 (11.5) 0.79
Received radical prostatectomy (%) 1787 (12.7%) 1 (1.5%) 0.01
Age in years (mean [SD]) 61.7 (6.5) *
Received non-radical prostatectomy (%) 5770 (40.8%) 24 (35.3%) 0.002
Age in years (mean [SD]) 73.8 (8.3) 71.4 (13.2) 0.15
Breast cancer
Women who had breast cancer surgery (%) 11055 (98.6%) 151 (1.4%)
Age in years (mean [SD]) 58.5 (14.0) 57.5 (13.6) 0.37
Received breast-conserving surgery rather than 
mastectomy (%)
5243 (47.6%) 71 (47.0%) 0.98
Age in years (mean [SD]) 57.6 (14.0) 57.6 (13.1) 0.97
* As only one Indigenous man underwent radical prostatectomy, his age is omitted to prevent identification.
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as has been found with breast cancer.18 An
Indigenous person may not have the finan-
cial resources, even with assistance pro-
grams, to travel for surgery and adjuvant
treatment or to pay for medications;18 this
may be compounded by a low rate of private
health insurance.1 Cultural and religious
barriers may also exist, such as sex of the
healthcare provider,17 religious denomina-
tion of the hospital or a preference for
traditional healing practices.19 There may
also be concerns about how the immediate
and extended family will cope with the
illness and treatment,18 especially in areas
lacking culturally sensitive aftercare serv-
ices.19 Importantly, there may be concerns
that treatment is ineffective and not worth-
while, especially for cancers with high case-
fatality rates, such as lung cancer.
From a healthcare system perspective,
plausible barriers exist at all stages of care.19
There are few Indigenous cancer specialists,
and non-Indigenous specialists may have
difficulty communicating effectively with
patients and their families,1,20 potentially
leading to paternalistic care3 and reduced
compliance with treatment.2,20 Coordinated
care between cancer centres, local hospitals
and primary care services is essential, but
service gaps are commonly reported.19 From
a clinical perspective, the low rates of surgi-
cal intervention for lung cancer in this study
may indicate that the cancers are more
advanced and less amenable to treatment in
the Indigenous population,21 or, alterna-
tively, there may be comorbidity17 or other
valid reasons why patients or surgeons have
decided that surgical treatment is not the
preferred option.20,22 Nevertheless, the
potential for systematic unintentional treat-
ment disparities remains.20,22
A number of policy options are available,
but the primary concern must be to reduce
social and health inequities for the Indi-
genous population.3,19 The results of this
study suggest four possible policies. Firstly,
research in the field to determine the rea-
sons for treatment choice and to ensure that
barriers to early treatment are mini-
mised.17,20,22 A second policy step is to
engage the Indigenous communities, and
together find appropriate strategies.3
Thirdly, administrative datasets have proved
useful in profiling morbidity and mortality
patterns in the non-Indigenous population,
but their use will remain limited in the
Indigenous population unless sufficient
cases are available for analysis. This could be
achieved by better identification of the
Indigenous population in the datasets and
interstate cooperation to merge de-identified
data. Finally, Indigenous issues must be
embedded in cancer control strategy plans,
and they must be implemented.
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